Humoral responses to pig-to-baboon cardiac transplantation: Implications for the pathogenesis and treatment of acute vascular rejection and for accommodation

Human Immunology

Volumn 58, Issue 2, 1997, Pages 91-105

  McCurry, Kenneth R ^a   Parker, William ^a   Cotterell, Adrian H ^a   Weidner, Bryan C ^a   Lin, Shu S ^a   Daniels, Larkin J ^a   Holzknecht, Zoie E ^a   Byrne, Guerard W ^b   Diamond, Lisa E ^b   Logan, John S ^b   Platt, Jeffrey L ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b Nextran   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA GALACTOSIDASE; AZATHIOPRINE; CARDIOPLEGIC AGENT; CD59 ANTIGEN; CYCLOSPORIN; DECAY ACCELERATING FACTOR; GALACTOSE; HUMORAL ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; NITROBLUE TETRAZOLIUM; OCTYL GLUCOSIDE; PLEGISOL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN BINDING; ANTIGEN EXPRESSION; ARTICLE; BABOON; CONTROLLED STUDY; GRAFT REJECTION; HEART TRANSPLANTATION; HUMORAL IMMUNITY; IMMUNOSUPPRESSIVE TREATMENT; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RECIPIENT; SWINE; TREATMENT OUTCOME; VASCULAR ENDOTHELIUM; XENOGRAFT; XENOTRANSPLANTATION;

ANIMALS; ANTIBODIES, HETEROPHILE; AORTA; BLOOD VESSELS; BLOTTING, WESTERN; COMPLEMENT FIXATION TESTS; ENDOTHELIUM, VASCULAR; ENZYME-LINKED IMMUNOSORBENT ASSAY; GRAFT REJECTION; HEART TRANSPLANTATION; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSION; INTEGRINS; MICROSCOPY, FLUORESCENCE; PAPIO; SWINE; TRANSPLANTATION, HETEROLOGOUS;

EID: 0031410288     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(97)00229-2     Document Type: Article

References (72)

1. Clark DS, Gewurz H, Good RA, Varco RL. Complement fixation during homograft rejection. Surg Forum. 15:1964;144.
2. Perper RJ, Najarian JS. Experimental renal heterotransplantation I. In widely divergent species . Transplantation. 4:1966;377.
3. Auchincloss H Jr. Xenogeneic transplantation. Transplantation. 46:1988;1.
4. Calne RY. Organ transplantation between widely disparate species. Transpl Proc. 2:1970;550.
5. Gewurz H, Clark DS, Cooper MD, Varco RL, Good RA. Effect of cobra venom-induced inhibition of complement activity on allograft and xenograft rejection reactions. Transplantation. 5:1967;1296.
6. Cooper DKC, Human PA, Lexer G, Rose AG, Rees J, Keraan M, Du Toit E. Effects of cyclosporine and antibody adsorption on pig cardiac xenograft survival in the baboon. J Heart Transpl. 7:1988;238.
7. Platt JL, Fischel RJ, Matas AJ, Reif SA, Bolman RM, Bach FH. Immunopathology of hyperacute xenograft rejection in a swine-to-primate model. Transplantation. 52:1991;214.
8. Brauer RB, Baldwin WM III, Daha MR, Pruitt SK, Sanfilippo F. Use of C6-deficient rats to evaluate the mechanism of hyperacute rejection of discordant cardiac xenografts. J Immunol. 151:1993;7240.
9. Saadi S, Platt JL. Transient perturbation of endothelial integrity induced by antibodies and complement. J Exp Med. 181:1995;21.
10. Saadi S, Ihrcke NS, Platt JL: Pathophysiology of xenograft rejection. In Lieberman R, Morris R (eds): Principles of immunomodulatory drug development in transplantation and autoimmunity. New York, NY: Raven Press, 1996.31.
11. Moberg AW, Shons AR, Gewurz H, Mozes M, Najarian JS. Prolongation of renal xenografts by the simultaneous sequestration of preformed antibody, inhibition of complement, coagulation and antibody synthesis. Transpl Proc. 3:1971;539.
12. Kaplon RJ, Michler RE, Xu H, Kwiatkowski PA, Edwards NM, Platt JL. Absence of hyperacute rejection in newborn pig-to-baboon cardiac xenografts. Transplantation. 59:1994;1.
13. Leventhal JR, Matas AJ, Sun LH, Reif S, Bolman RM III, Dalmasso AP, Platt JL. The immunopathology of cardiac xenograft rejection in the guinea pig to rat model. Transplantation. 56:1993;1.
14. Platt JL. A perspective on xenograft rejection and accommodation. Immunol Rev. 141:1994;127.
15. Magee JC, Collins BH, Harland RC, Lindman BJ, Bollinger RR, Frank MM, Platt JL. Immunoglobulin prevents complement mediated hyperacute rejection in swine-to-primate xenotransplantation. J Clin Invest. 96:1995;2404.
16. Platt JL, Vercellotti GM, Dalmasso AP, Matas J, Bolman RM, Najarian JS, Bach FH. Transplantation of discordant xenografts A review of progress . Immunol Today. 11:1990;450.
17. Blakely ML, Van Der Werf WJ, Berndt MC, Dalmasso AP, Bach FH, Hancock WW. Activation of intragraft endothelial and mononuclear cells during discordant xenograft rejection. Transplantation. 58:1994;1059.
18. Parker W, Saadi S, Lin SS, Holzknecht ZE, Bustos M, Platt JL. Transplantation of discordant xenografts A challenge revisited . Immunol Today. 17:1996;373.
19. Cotterell AH, Collins BH, Parker W, Harland RC, Platt JL. The humoral immune response in humans following cross-perfusion of porcine organs. Transplantation. 60:1995;861.
20. Satake M, Kawagishi N, Rydberg L, Samuelsson BE, Tibell A, Groth C, Moller E. Limited speicificity of xenoantibodies in diabetic patients transplanted with fetal porcine islet cell clusters Main antibody reactivity against α-linked galactose-containing epitopes . Xenotransplantation. 1:1994;89.
21. Alexandre GPJ, Gianello P, Latinne D, Carlier M, Dewaele A, Van Obbergh L, Moriau M, Marbaix E, Lambotte JL, Lambotte L, Squifflet JP: Plasmapheresis and splenectomy in experimental renal xenotransplantation. In Hardy MA (ed): Xenograft 25. New York, NY: Elsevier Science Publishers, 1989; 259.
22. Leventhal JR, John R, Fryer JP, Witson JC, Derlich J, Remiszewski J, Dalmasso A, Matas A, Bolman R. Removal of baboon and human antiporcine IgG and IgM natural antibodies by immunoadsorption Results of in vitro and in vivo studies . Transplantation. 59:1995;294.
23. Sachs DH, Sablinski T. Tolerance across discordant xenogeneic barriers. Xenotransplantation. 2:1995;234.
24. Thompson C. Humanised pigs hearts boost xenotransplantation. Lancet. 346:1995;766.
25. Paul LC, Claas FJH, van Es LA, Kalff MW, de Graeff J. Accelerated rejection of a renal allograft associated with pretransplantation antibodies directed against donor antigens on endothelium and monocytes. New Eng J Med. 300:1979;1258.
26. Abbas AK, Corson JM, Carpenter CB, Galvanek EG, Merrill JP, Dammin GJ. Immunologic enhancement of rat renal allografts. Am J Pathol. 75:1974;271.
27. Hasan R, van den Bogaerde JB, Wallwork J, White DJG. Evidence that long-term survival of concordant xenografts is achieved by inhibition of antispecies antibody production. Transplantation. 54:1992;408.
28. Fujino Y, Kawamura T, Hullett DA, Sollinger HW. Evaluation of cyclosporine, mycophenolate mofetil, and brequinar sodium combination therapy on hamster-to-rat cardiac xenotransplantation. Transplantation. 57:1994;41.
29. Perper RJ, Najarian JS. Experimental renal heterotransplantation III. Passive transfer of transplantation immunity . Transplantation. 5:1967;514.
30. Galili U, Tibell A, Samuelsson B, Rydberg L, Groth CG. Increased anti-gal activity in diabetic patients transplanted with fetal porcine islet cell clusters. Transplantation. 59:1995;1549.
31. Diamond LE, McCurry KR, Oldham ER, McClellan SB, Martin MJ, Platt JL, Logan JS. Characterization of transgenic pigs expressing functionally active human CD59 on cardiac endothelium. Transplantation. 61:1996;1241.
32. Byrne GW, McCurry KR, Martin MJ, McClellan SM, Platt JL, Logan JS. Transgenic pigs expressing human CD59 and decay-accelerating factor produce an intrinsic barrier to complement-mediated damage. Transplantation. 63:1997;149.
33. Schwartz ME, Podesta L, Morris M, Makowka L, Miller CM: Donor management, techniques and procurement. In Makowka L (ed): The handdbook of transplantation management. Austin, TX: R.G.Landes Co.; 1991; 44.
34. McCurry KR, Kooyman DL, Alvarado CG, Cotterell AH, Martin MJ, Logan JS, Platt JL. Human complement regulatory proteins protect swine-to-primate cardiac xenografts from humoral injury. Nature Med. 1:1995;423.
35. Michler RE, McManus RP, Smith CR, Sadeghi AN, Rose EA. Technique for primate heterotopic cardiac xenotransplantation. J Med Primatol. 14:1985;357.
36. Parker W, Bruno D, Holzknecht ZE, Platt JL. Xenoreactive natural antibodies isolation and initial characterization . J Immunol. 153:1994;3791.
37. Platt JL, Grant BW, Eddy AA, Michael AF. Immune cell populations in cutaneous delayed-type hypersensitivity. J Exp Med. 158:1983;1227.
38. Platt JL, Turman MA, Noreen HJ, Fischel RJ, Bolman RM, Bach FH. An ELISA assay for xenoreactive natural antibodies. Transplantation. 49:1990;1000.
39. Collins BH, Parker W, Platt JL. Characterization of porcine endothelial cell determinants recognized by human natural antibodies. Xenotransplantation. 1:1994;36.
40. Parker W, Lateef J, Everett ML, Platt JL. Specificity of xenoreactive anti-galα1-3gal IgM for α-galactosyl ligands. Glycobiology. 6:1996;499.
41. Yu PB, Holzknecht ZE, Bruno D, Parker W, Platt JL. Modulation of natural IgM binding and complement activation by natural IgG antibodies. J Immunol. 157:1996;5163.
42. Platt JL, Holzknecht ZE. Porcine platelet antigens recognized by human xenoreactive natural antibodies. Transplantation. 57:1994;327.
43. Holzknecht ZE, Platt JL. Identification of porcine endothelial cell membrane antigens recognized by human xenoreactive antibodies. J Immunol. 154:1995;4565.
44. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680.
45. Platt JL, Vercellotti GM, Lindman BJ, Oegema TR Jr, Bach FH, Dalmasso AP. Release of heparan sulfate from endothelial cells Implications for pathogenesis of hyperacute rejection . J Exp Med. 171:1990;1363.
46. Saadi S, Holzkhecht RA, Patte CP, Stern DM, Platt JL. Complement-mediated regulation of tissue factor activity in endothelium. J Exp Med. 182:1995;1807.
47. Good AH, Cooper DKS, Malcolm AJ, Ippolito RM, Koren E, Neethling FA, Ye Y, Zuhdi N, Lamontagne LR. Identification of carbohydrate structures that bind human antiporcine antibodies Implications for discordant xenografting in humans . Transpl Proc. 24:1992;559.
48. Sandrin MS, Vaughan HA, Dabkowski PL, McKenzie IFC. Anti-pig IgM antibodies in human serum react predominantly with Galα(1,3)Gal epitopes. Proc Natl Acad Sci USA. 90:1993;11391.
49. Parker W, Lundberg-Swanson KL, Holzknecht ZE, Lateef J, Washburn SA, Braedehoeft SJ, Platt JL. Isohemagglutinins and xenoreactive antibodies are members of a distinct family of natural antibodies. Hum Immunol. 45:1996;94.
50. Gewurz H, Clark DS, Finstad J, Kelly WD, Varco RL, Good RA, Gabrielsen AE. Role of the complement system in graft rejections in experimental animals and man. Ann N Y Acad Sci. 129:1966;673.
51. Giles GR, Boehmig HJ, Lilly J, Amemiya H, Takagi H, Coburg AJ, Hathaway WE, Wilson CB, Dixon FJ, Starzl TE. Mechanism and modification of rejection of heterografts between divergent species. Transpl Proc. 2:1970;522.
52. Hammer C. Isohemagglutinins and preformed natural antibodies in xenogeneic organ transplantation. Transpl Proc. 19:1987;4443.
53. Galili U. Interaction of the natural anti-Gal antibody with α-galactosyl epitopes a major obstacle for xenotransplantation in humans . Immunol Today. 14:1993;480.
54. Collins BH, Cotterell AH, McCurry KR, Alvarado CG, Magee JC, Parker W, Platt JL. Cardiac xenografts between primate species provide evidence for the importance of the α-galactosyl determinant in hyperacute rejection. J Immunol. 154:1995;5500.
55. Ballantyne DL, Nathan P. Use of sequential skin allografts to demonstrate sensitization induced by short-term kidney transplants. Transplantation. 6:1968;342.
56. McPaul JJ, Stastny P, Freeman RB. Specificities of antibodies eluted from human cadaveric renal allografts. J Clin Invest. 67:1981;1405.
57. Knechtle SJ, Kolbeck PC, Tsuchimoto S, Coundouriotis A, Sanfilippo F, Bollinger RR. Hepatic transplantation into sensitized recipients demonstration of hyperacute rejection . Transplantation. 43:1987;8.
58. Cooper DKS, Human PA, Rose AG, Reese J, Keraan M, Reichart B, Toit ED, Oriol R. The role of ABO blood group compatibility in heart transplantation between closely related animal species. J Thor Cardiovas Surg. 97:1989;447.
59. Hynes RO. Integrins versatility, modulation, and signaling in cell adhesion . Cell. 69:1992;11.
60. Schwartz MA, Ingber DE, Lawrence M, Springer TA, Lechene C. Multiple integrins share the ability to induce elevation of intracellular pH. Exp Cell Res. 195:1991;533.
61. Lampugnani MG, Resnati M, Dejana E, Marchisio PC. The role of integrins in the maintenance of endothelial monolayer integrity. J Cell Biol. 112:1991;479.
62. Miyamoto S, Aklyama SK, Yamada K. Synergistic roles for receptor occupancy and aggregation in integrin transmembrane function. Science. 267:1995;883.
63. Kornberg LJ, Earp HS, Turner CE, Prockop C, Juliano RL. Signal transduction by integrins increased protein tyrosine phosphorylation caused by clustering of b1 integrins . Proc Natl Acad Sci USA. 88:1991;8392.
64. Vercellotti GM, Platt JL, Bach FH, Dalmasso AP. Neutrophil adhesion to xenogeneic endothelium via iC3b. J Immunol. 146:1991;730.
65. Saadi S, Platt JL: Endothelial cell responses to complement activation. In Volanakis JE, Frank MM (eds): The Human Complement System on Health and Disease. New York, Marcel Dekker (in press).
66. Ihrcke NS, Platt JL. Shedding of heparan sulfate proteoglycan by stimulated endothelial cells evidence for proteolysis of cell surface molecules . J Cell Physiol. 168:1996;625.
67. Inverardi L, Samaja M, Motterlini R, Mangili F, Bender JR, Pardi R. Early recognition of a discordant xenogeneic organ by human circulating lymphocytes. J Immunol. 149:1992;1416.
68. Ihrcke NS, Wrenshall LE, Lindman BJ, Platt JL. Role of heparan sulfate in immune system-blood vessel interactions. Immunol Today. 14:1993;500.
69. Sharma A, Okabe JF, Birch P, Platt JL, Logan JS. Reduction in the level of gal (α1,3) gal in transgenic mice and pigs by the expression of an α(1,2) fucosyltransferase. Proc Natl Acad Sci USA. 93:1996;7190.
70. Chopek MW, Simmons RL, Platt JL. ABO incompatible renal transplantation Initial immunopathologic evaluation . Transpl Proc. 19:1987;4553.
71. Lawson JH, Platt JL. Molecular barriers to xenotransplantation. Transplantation. 62:1996;303.
72. Malyguine AM, Saadi S, Platt JL, Dawson JR. Human natural killer cells induce morphologic changes in porcine endothelial cell monolayers. Transplantation. 61:1996;161.